Foundation date



#Professional Services and Consulting


ISMS is an analytic and dynamic team realizing market access results in the healthcare industry. We provide valuation of assets and substantiate value to ensure product reimbursement with a good price positioning, both in support of early development and to realize launch. With our multidisciplinary approach, bridging science and business, we provide a broad experience in terms of drug development (target product profile, outcome selection), health economics (value dossiers, pricing, cost-effectiveness and budget impact models) and further value & scientific communication, stakeholder negotiations and business & analytics modelling. We work with global pharma companies as well as biotech companies and are passionate to share our experience with you!

Upcoming events

Latest news

  • Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

    2 hours ago

  • Triple discovery unveils insights into type 2 diabetes

    Thursday September 28th 2023

  • SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

    Wednesday September 27th 2023